Multiple components contribute to ability of saliva to inhibit influenza viruses

Oral Microbiology and Immunology

Volumn 24, Issue 1, 2009, Pages 18-24

  White, M R ^a   Helmerhorst, E J ^b   Ligtenberg, A ^c   Karpel, M ^a   Tecle, T ^a   Siqueira, W L ^b   Oppenheim, F G ^b   Hartshorn, K L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Histatins; Innate immunity; MUC5B

Indexed keywords

AMYLASE; DEFENSIN; GLYCOPROTEIN; HISTATIN; MUCIN 5B; OSELTAMIVIR; SALIVA PROTEIN; SALIVARY GLYCOPROTEIN 340; SERUM LEUKOCYTE PROTEASE INHIBITOR; SIALIDASE; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; HEMAGGLUTINATION INHIBITION TEST; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; INFLUENZA VIRUS A; NONHUMAN; PAROTID GLAND; SALIVA; SALIVATION; SUBMANDIBULAR GLAND; VIRUS INHIBITION;

ANTIVIRAL AGENTS; DEFENSINS; ENZYME INHIBITORS; HEMAGGLUTINATION INHIBITION TESTS; HISTATINS; HIV-1; HUMANS; INFLUENZA A VIRUS; MUCIN-5B; NEURAMINIDASE; NEUTRALIZATION TESTS; OSELTAMIVIR; PAROTID GLAND; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SUBMANDIBULAR GLAND;

EID: 57649231172     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2008.00468.x     Document Type: Article

References (37)

1. Archibald DW, Cole GA. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses 1990 : 6 : 1425 1432.
2. Bolscher JG, Nazmi K, Ran LJ et al. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci 2002 : 110 : 149 156.
3. Crombie R, Kawasaki K, Hojo K, Laurence J. Peptides derived from salivary thrombospondin-1 replicate its anti-HIV effect: potential role in microbicide development. J Acquir Immune Defic Syndr 2001 : 27 : 91 93.
4. Crombie R, Silverstein RL, MacLow C, Pearce SF, Nachman RL, Laurence J. Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 1998 : 187 : 25 35.
5. den Hertog AL, van Marle J, van Veen HA et al. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 2005 : 388 : 689 695.
6. Groot F, Sanders RW, ter Brake O et al. Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J Virol 2006 : 80 : 9236 9243.
7. Habte HH, Mall AS, de Beer C, Lotz ZE, Kahn D. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of human immunodeficiency virus type 1 in an inhibition assay. Virol J 2006 : 3 : 99.
8. Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E. Interactions of recombinant human pulmonary surfactant protein D and SPD multimers with influenza A. Am J Physiol 1996 : 271 : L753 762.
9. Hartshorn KL, Collamer M, Auerbach M, Myers JB, Pavlotsky N, Tauber AI. Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol 1988 : 141 : 1295 1301.
10. Hartshorn KL, Crouch EC, White MR et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 1994 : 94 : 311 319.
11. Hartshorn KL, Ligtenberg A, White MR et al. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J 2006 : 393 : 545 553.
12. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 2003 : 285 : L1066 1076.
13. Hartshorn KL, White MR, Tecle T, Holmskov U, Crouch EC. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol 2006 : 176 : 6962 6972.
14. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J 2000 : 351 Pt 2 : 449 458.
15. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007 : 86 : 680 693.
16. Jayasekera JP, Moseman EA, Carroll MC. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 2007 : 81 : 3487 3494.
17. Jensen JL, Lamkin MS, Oppenheim FG. Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions. J Dent Res 1992 : 71 : 1569 1576.
18. Kandel R, Hartshorn KL. Novel strategies for prevention and treatment of influenza. Expert Opin Ther Targets 2005 : 9 : 1 22.
19. Kazmi SH, Naglik JR, Sweet SP et al. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006 : 13 : 1111 1118.
20. LeVine A, Whitsett J, Hartshorn K, Korfhagen T. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001 : 167 : 5868 5873.
21. Ligtenberg AJ, Bikker FJ, De Blieck-Hogervorst JM, Veerman EC, Nieuw Amerongen AV. Binding of salivary agglutinin to IgA. Biochem J 2004 : 383 : 159 164.
22. Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV, Mollenhauer J. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem 2007 : 388 : 1275 1289.
23. Ligtenberg TJ, Bikker FJ, Groenink J et al. Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J 2001 : 359 : 243 248.
24. Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ. Salivary proteome and its genetic polymorphisms. Ann N Y Acad Sci 2007 : 1098 : 22 50.
25. Robinovitch MR, Ashley RL, Iversen JM, Vigoren EM, Oppenheim FG, Lamkin M. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity. Oral Dis 2001 : 7 : 86 93.
26. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME. Alpha-defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis 2007 : 196 : 835 843.
27. Sano H, Nagai K, Tsutsumi H, Kuroki Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur J Immunol 2003 : 33 : 2894 2902.
28. Skott P, Lucht E, Ehnlund M, Bjorling E. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism. Oral Dis 2002 : 8 : 160 167.
29. Soares RV, Lin T, Siqueira CC et al. Salivary micelles: identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch Oral Biol 2004 : 49 : 337 343.
30. Soares RV, Siqueira CC, Bruno LS, Oppenheim FG, Offner GD, Troxler RF. MG2 and lactoferrin form a heterotypic complex in salivary secretions. J Dent Res 2003 : 82 : 471 475.
31. Tecle T, White MR, Crouch EC, Hartshorn KL. Inhibition of influenza viral neuraminidase activity by collections. Arch Virol 2007 : 152 : 1731 1742.
32. Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 2007 : 178 : 8046 8052.
33. Trampuz A, Prabhu RM, Smith TF, Baddour LM. Avian influenza: a new pandemic threat? Mayo Clin Proc 2004 : 79 : 523 530.
34. Veerman EC, van den Keybus PA, Valentijn-Benz M, Nieuw Amerongen AV. Isolation of different high-Mr mucin species from human whole saliva. Biochem J 1992 : 283 (Pt 3) : 807 811.
35. Webby RJ, Webster RG. Are we ready for pandemic influenza? Science 2003 : 302 : 1519 1522.
36. White MR, Crouch E, van Eijk M et al. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol 2005 : 288 : L831 840.
37. White MR, Tecle T, Crouch EC, Hartshorn KL. Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid. Am J Physiol Lung Cell Mol Physiol 2007 : 293 : L1293 1299.